Aclaris Therapeutics, Inc. (ACRS:NASDAQ) closed at $3.28 on October 16, 2026, down 6.02% on the day. The stock trades 50.3% below its 52-week high of $6.60 and 74.5% above its 52-week low of $1.88. Over the past year, it gained 72.6%. Aclaris Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -8.89% | -39.26% | -41.11% | -22.82% | +72.63% |
In 252 trading sessions since October 16, 2025, ACRS closed higher on 124 days (49%). Its best day was January 20, 2026 (+69.08%) and its worst was October 1, 2026 (-16.16%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 2 times.
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
Find more stocks like ACRS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.